Management of poultry manure in Poland : current state and future perspectives

This review aimed to analyse the current state of management practices for poultry manure in Poland and present future perspectives in terms of technologies allowing closing the loops for circular economy, and thus recovery of nutrients and energy. The scope of the review focused primarily on: (1) the analysis of poultry production and generation of poultry manure with special references to quantities, properties (e.g. fertilizing properties), seasonality, etc.; (2) the overview of current practices and methods for managing poultry manure including advantages and limitations; (3) the analysis of potential and realistic threats and risk related to managing poultry manure, and also (4) the analysis of promising technologies for converting poultry manure into added value products and energy. The review addressed the following technologies: composting of poultry manure to obtain fertilizers and soil improvers, anaerobic digestion of poultry manure for energy recovery, and also pyrolysis of poultry manure into different types of biochar that can be applied in agriculture, horticulture and industry. Poultry manure is rich in macro- and micronutrients but also can contain various contaminants such as antibiotics or pesticides, and thus posing a realistic threat to soil and living organisms when applied to soil directly or after biological treatment. The main challenge in poultry manure processing is to assure sufficient closing of carbon, nitrogen and phosphorous loops and safe application to soil

Resource recovery and life cycle assessment in co‐treatment of organic waste substrates for biogas versus incineration value chains in Poland and Norway

Present waste management policies are characterized by some main shifts compared to previous practices; such as increased focus on resources recovery, banning of landfilling of organic waste fractions, waste-to-energy value chains optimization, and environmental life cycle impact optimization. In order to comply with such new policies there is a need for research on methodological and empirical aspects of LCA for value chains for co-treatment and resource recovery from organic waste substrates; including processes from generation, treatment, energy conversion and final use of products and byproducts. This study examines two generic value chains (aiming at what are common solutions) for co-treatment of selected organic waste substrates, converted to energy, in Norway and Poland. The waste substrates that are studied are sewage sludge (46% dry matter), organic fractions of municipal solid waste (27.1%), and fat (26.9), in different combinations of quantity mix. Chemical properties for these substrates are gathered from a newly executed state-of-the-art analysis in addition to comprehensive laboratory experiments to find methane yield characteristics of different co-treatment substrate mix situations. Technologies examined in this study include pretreatment, anaerobic digestion, biogas upgrading to CHP-generation or to biofuel for use in transport, bioresiduals separation or upgrading to compost for use in agriculture or as soil amendment, all as part of an anaerobic route, compared to waste incineration with energy recovery to CHP-generation as alternative to the anaerobic route. Products and byproducts of both treatment options are substituting mineral fertilizers, fossil fuels and electricity grid mixes common of today, by system expansion, to determine possible avoided impacts when comparing alternative technologies. The LCA model is based on input from a feedstock-driven and mass-balance consistent MFA model that estimates the life cycle inventory. This provides increased flexibility and accuracy regarding system and technology assumptions, on the basis of a given set of transfer coefficients and parameters that can be altered according to what value chain and technologies are to be examined. This study presents LCA results from two defined and alternative value chains, based on what are typical assumptions and input variable values for applications in a Norwegian and in a Polish setting. The study account for the differences in technologies and practices in the typical waste systems, the typical energy systems and the typical transportation systems in each country, where the main differences between the two systems are that bioresidual is used as fertilizer in Norway and not in Poland additional to the different electricity mixes. LCA calculations are performed using different mix ratios of incoming waste substrates (sewage sludge, organic waste, fat), and assessing the corresponding energy recovery efficiency, nutrient recovery efficiency, and the associated impacts affected by applied technologies, transport distances, carbon capture potential, as well as estimating direct emissions for CH4, N2O and NH3, according to chosen end-use practices within the systems. The study shows what are the main important system processes and elements and what turn to be the critical variables and assumptions in the LCA modeling. It also gives recommendations for what factors to focus when trying to improve the resource recovery for energy and nutrients and the life-cycle environmental impacts of organic waste-to-energy value chains

Transcriptomic Comparison of Human Peripartum and Dilated Cardiomyopathy Identifies Differences in Key Disease Pathways

Peripartum cardiomyopathy (PPCM) is a rare form of acute onset heart failure that presents in otherwise healthy pregnant women around the time of delivery. While most of these women respond to early intervention, about 20% progress to end-stage heart failure that symptomatically resembles dilated cardiomyopathy (DCM). In this study, we examined two independent RNAseq datasets from the left ventricle of end-stage PPCM patients and compared gene expression profiles to female DCM and non-failing donors. Differential gene expression, enrichment analysis and cellular deconvolution were performed to identify key processes in disease pathology. PPCM and DCM display similar enrichment in metabolic pathways and extracellular matrix remodeling suggesting these are similar processes across end-stage systolic heart failure. Genes involved in golgi vesicles biogenesis and budding were enriched in PPCM left ventricles compared to healthy donors but were not found in DCM. Furthermore, changes in immune cell populations are evident in PPCM but to a lesser extent compared to DCM, where the latter is associated with pronounced pro-inflammatory and cytotoxic T cell activity. This study reveals several pathways that are common to end-stage heart failure but also identifies potential targets of disease that may be unique to PPCM and DCM.</p

Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?

We investigated the clinical impact of elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in the context of neoadjuvant chemotherapy (CTx) in gastric/gastro-oesophageal adenocarcinomas. We analysed 583 resected tumours (272 without and 311 after CTx) and 142 tumour biopsies before CTx. If at least two or three of the five tetranucleotide repeat markers tested showed instability, the tumours were defined as EMAST (2+) or EMAST (3+), respectively. Expression of mismatch repair proteins including MSH3 was analysed using immunohistochemistry. Microsatellite instability (MSI) and Epstein-Barr virus (EBV) positivity were determined using standard assays. EMAST (2+) and (3+) were detected in 17.8 and 11.5% of the tumours, respectively. The frequency of EMAST (2+) or (3+) in MSI-high (MSI-H) tumours was 96.2 or 92.5%, respectively, demonstrating a high overlap with this molecular subtype, and the association of EMAST and MSI status was significant (each overall p < 0.001). EMAST (2+ or 3+) alone in MSI-H and EBV-negative tumours demonstrated only a statistically significant association of EMAST (2+) positivity and negative lymph node status (42.3% in EMAST (2+) and 28.8% in EMAST negative, p = 0.045). EMAST alone by neither definition was significantly associated with overall survival (OS) of the patients. The median OS for EMAST (2+) patients was 40.0 months (95% confidence interval [CI] 16.4-63.6) compared with 38.7 months (95% CI 26.3-51.1) for the EMAST-negative group (p = 0.880). The median OS for EMAST (3+) patients was 46.7 months (95% CI 18.2-75.2) and 38.7 months (95% CI 26.2-51.2) for the negative group (p = 0.879). No statistically significant association with response to neoadjuvant CTx was observed (p = 0.992 and p = 0.433 for EMAST (2+) and (3+), respectively). In conclusion, our results demonstrate a nearly complete intersection between MSI-H and EMAST and they indicate that EMAST alone is not a distinct instability type associated with noticeable clinico-pathological characteristics of gastric carcinoma patients

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

BACKGROUND: Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months. METHODS: We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia. Patients (age >18 years) with suspected STEMI and who were eligible for PPCI were randomly allocated (1:1, stratified by centre with a permuted block method) to receive standard treatment (including a sham simulated remote ischaemic conditioning intervention at UK sites only) or remote ischaemic conditioning treatment (intermittent ischaemia and reperfusion applied to the arm through four cycles of 5-min inflation and 5-min deflation of an automated cuff device) before PPCI. Investigators responsible for data collection and outcome assessment were masked to treatment allocation. The primary combined endpoint was cardiac death or hospitalisation for heart failure at 12 months in the intention-to-treat population. This trial is registered with ClinicalTrials.gov (NCT02342522) and is completed. FINDINGS: Between Nov 6, 2013, and March 31, 2018, 5401 patients were randomly allocated to either the control group (n=2701) or the remote ischaemic conditioning group (n=2700). After exclusion of patients upon hospital arrival or loss to follow-up, 2569 patients in the control group and 2546 in the intervention group were included in the intention-to-treat analysis. At 12 months post-PPCI, the Kaplan-Meier-estimated frequencies of cardiac death or hospitalisation for heart failure (the primary endpoint) were 220 (8·6%) patients in the control group and 239 (9·4%) in the remote ischaemic conditioning group (hazard ratio 1·10 [95% CI 0·91-1·32], p=0·32 for intervention versus control). No important unexpected adverse events or side effects of remote ischaemic conditioning were observed. INTERPRETATION: Remote ischaemic conditioning does not improve clinical outcomes (cardiac death or hospitalisation for heart failure) at 12 months in patients with STEMI undergoing PPCI. FUNDING: British Heart Foundation, University College London Hospitals/University College London Biomedical Research Centre, Danish Innovation Foundation, Novo Nordisk Foundation, TrygFonden

Treatment of Landfill Leachate Using Ultrasound Assisted SBR Reactor

The article investigated the effects of ultrasound pretreatment on biological treatment of landfill leachate. Leachates with and without conditioning were combined with municipal wastewater at different ratios. The study showed that the implementation of a pretreatment step prior to biological treatment not only results in higher pollutant removal efficiency but may also allow for an increased leachate volume share in the influent stream entering the reactor by up to 20% (quality of effluents meets national regulation requirements) which in scenarios without pretreatment cannot exceed 5% due to poor quality of the effluents

Sewage Sludge-Derived Biochar and Its Potential for Removal of Ammonium Nitrogen and Phosphorus from Filtrate Generated during Dewatering of Digested Sludge

Utilizing waste, such as sewage sludge, into biochar fits the circular economy concept. It maximizes the reuse and recycling of waste materials in the wastewater treatment plant. The experiments were conducted to assess: (1) the impact of the temperature on the properties of biochar from sewage sludge (400 °C, 500 °C, 600 °C, 700 °C); (2) how the physical activation (CO2, hot water) or chemical modification using (MgCl2, KOH) could affect the removal of ammonia nitrogen and phosphorus from filtrate collected from sludge dewatering filter belts or synthetic solution, wherein the concentration of ammonium nitrogen and phosphorus were similar to the filtrate. Based on the Brunner–Emmett–Teller (BET) surface and the type and concentration of surface functional groups for the second stage, biochar was selected and produced at 500 °C. The modification of biochar had a statistically significant effect on removing nitrogen and phosphorus from the media. The best results were obtained for biochar modified with potassium hydroxide. For this trial, 15%/17% (filtrate/synthetic model solution) and 72%/86% nitrogen and phosphorus removal, respectively, were achieved

Pretreatment methods as a means of boosting methane production from sewage sludge and its mixtures with grease trap sludge

The main objective of this study was to determine the applicability of the selected pretreatment methods as a means of intensification of methane production from sewage sludge as well as its mixtures with grease trap sludge. The addition of the fat rich material to the digester treating sewage sludge resulted in an increased methane yield as well as volatile solids (VS) removal of up to 36% (from 134.75 mL/g VS to 182.84 mL/g VS). Furthermore, thermochemical pretreatment of the co-digestion mixture resulted in an approximately 76% higher methane yield as compared to the untreated sewage sludge. The energy balance showed that, for both materials ultrasonic pretreatment and thermochemical pretreatment has an energy self-sufficiency. All of the tested models fit the experimental data with coefficients of determination higher than 0.96

The Application of an Upflow Anaerobic Sludge Blanket Reactor in the Treatment of Brewery and Dairy Wastewater: A Critical Review

Brewery (BW) and dairy (DW) wastewater are two types of agro-industrial wastewater that are generated in large amounts and, therefore, should be treated effectively and in an environmentally beneficial manner. Both these wastewater types are characterized by a high COD, BOD5, and nutrient content, and conventional wastewater treatment methods such as an activated sludge process may prove to be inefficient due to the possibility of foaming, large biomass production, low activity at low temperatures, and risk of overloading the reactor with a load of organic pollutants. In the context of the described difficulties, anaerobic processes seem to be the best alternative. An interesting research area is the co-digestion of these wastewaters. However, this research direction, so far, has not been frequently reported. Given the gap in the current knowledge, this literature review aims to assess the possibility of BW and DW digestion in anaerobic reactors and provide up-to-date data on the post-treatment methods of effluent generated after the anaerobic digestion process. Despite numerous advantages, anaerobic treatment often requires post-effluent treatment to complete the treatment cycle